NCT Number: NCT00006169
Behavioral Treatment of Weight Gain in CF
The current study examines the efficacy of two treatments to help children with cystic fibrosis (CF) meet their dietary calorie requirements of 120% to 150% of the recommended daily allowance of energy and the effect of these treatments on weight gain and maintenance. One treatment provides children with CF and their parents nutrition education about the best foods for meeting their dietary needs. The second treatment gives children with CF and their families similar nutritional information plus behavioral parenting methods for motivating children to eat the recommended foods. Children with CF and their families are seen weekly for 7 treatment sessions across 9 weeks for the active phase of treatment. Families are then followed for 2 years after treatment in order to better understand how long the treatments are effective and to determine the health benefits of better nutrition status and weight gain.
Looking for future studies?
Notify MeKey information
Conditions
Age range
4 year–12 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 3
Primary location
University of Florida, Gainesville, Florida, United States
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Weight percentile for age or height below 40th for age and sex
- Pancreatic insufficiency
Exclusion criteria
- Developmental delays
- Pseudomonas cepacia
- Supplemental enteral or parenteral nutrition
Treatment and study plan
Interested in participating?
Looking for future studies?
Notify MeSponsors and collaborators
Lead sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Nih
Registry information
Important dates
- Study start
- 1996
- Study completion
- 1999
- First posted
- Aug 9, 2000
- Registry last updated
- Mar 2, 2010
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
STaph Aureus Resistance-Treat Early and Repeat (STAR-TER)
NCT03489629
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis
Denver, Colorado, United States
View Trial DetailsEvaluation of Lung T1-MRI in Pediatric Cystic Fibrosis Patients
NCT04994301
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis
Indianapolis, Indiana, United States
View Trial DetailsComparison of Physical Activity, Exercise Capacity, Quality of Life, Cognitive Function and Coronavirus Phobia Levels of Adult Cystic Fibrosis Patients With Healthy Individuals With Telerehabilitation
NCT04673331
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis
Ankara, Turkey (Türkiye)
View Trial DetailsSildenafil Exercise: Role of PDE5 Inhibition
NCT04039087
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis
Denver, Colorado, United States
View Trial Details